N/A
Completed N=186
Preventing Addiction Related Suicide (PARS)
Source: ClinicalTrials.gov NCT03166709 ↗Enrolled (actual)
186
Serious AEs
0.5%
Results posted
Aug 2025
Primary outcomePrimary: PARS Help-Seeking Scale — 0.57; 0.53 units on a scale
Summary
The goal of this study is to evaluate the effectiveness and utility of the investigator's National Institute on Drug Abuse (NIDA) R21 developed "Preventing Addiction Related Suicide" (PARS) program by utilizing a novel stepped wedge design to evaluate PARS as a selected prevention program to increase help-seeking by clients in community addiction treatment.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY PARS Help-Seeking Scale |
0.57; 0.53 | — |
| PRIMARY PARS Suicide Knowledge Scale |
7.47; 8.24 | — |
| PRIMARY PARS Attitude Scale |
12.29; 11.14 | — |
| SECONDARY Suicidal Behavior Questionnaire - Revised |
4.54; 4.82 | — |
Eligibility Criteria
Inclusion Criteria
- Enrolled client in one of the community treatment settings
- Over 18 years of age (no maximum age)
- Ability to understand written and spoken English
Exclusion Criteria
- Any clinical medical/psychiatric condition, severity of that condition, or life situation that in the opinion of the counselors or Drs. Comtois or Ries would compromise safe and voluntary study participation (e.g., psychosis, custody conflict). This is expected to be a rare circumstance and will be known prior to the recruitment session. If a counselor does not want someone involved, they will not be. If counselor is unsure, Dr. Comtois or Ries will facilitate decision with counselor ahead of time to assist in the decision.
Data sourced from ClinicalTrials.gov (NCT03166709). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.